Skip to main content

Prostate Cancer Foundation awards grant to Coombs

December 17, 2019

The Prostate Cancer Foundation has awarded $225,000 across three years to UNC Lineberger’s Catherine C. Coombs, MD, to study whether genetic mutations that accumulate in the blood over time are linked to worse outcomes for prostate cancer. Coombs, an assistant professor in the UNC School of Medicine Division of Hematology/Oncology, received the Young Investigator Award … Continued

Lung Cancer Initiative awards research grant to Du to investigate novel treatment

December 16, 2019

The Lung Cancer Initiative of North Carolina (LCI) has awarded The Vicky Amidon Innovation in Lung Cancer Research Award to Hongwei Du, PhD, a postdoctoral fellow at University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The award also was presented to Kenneth Adler, PhD, at the North Carolina State University College … Continued

Cancer science goes high-tech with advancements in computational medicine

December 16, 2019

UNC Lineberger researchers are betting that computer technology that has made self-driving cars and facial recognition possible could play a role in the next big cancer research discovery. “It’s the future of medicine,” said UNC Lineberger’s Charles M. Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology in the Department of Genetics and … Continued

UNC Lineberger faculty honored for highly cited research

December 1, 2019

The Web of Science Group’s 2019 Highly Cited Researchers list recognized 18 UNC Lineberger members for being among the world’s most influential researchers of the past decade. The listing is limited to researchers who have published multiple highly-cited papers that rank in the top 1 percent by citations for field and year. Approximately only 6,200 … Continued

Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment

November 18, 2019

The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.

UNC Lineberger members go to Washington to highlight importance of research funding

May 18, 2016

Chad Ellis, PhD, Ben Major, PhD, and Anne-Marie Meyer, PhD, traveled to the U.S. Capitol to meet with members of the North Carolina congressional delegation and explain the impact of National Institutes of Health and National Cancer Institute funding on the lives and well-being of people in North Carolina and the country.